C-peptide and glucagon profiles in minority children with type 2 diabetes mellitus

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 4, 2001, Pages 1605-1609

  Umpaichitra, Vatcharapan ^a,b,c   Bastian, William ^a,b   Taha, Doris ^a,b   Banerji, Mary A ^a   Avruskin, Theodore W ^b,c   Castells, Salvador ^a,b,d  

^a Department of Pediatrics ^*  (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A1C;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; INSULIN DEFICIENCY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SEXUAL MATURATION;

EID: 0035035149     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.4.7415     Document Type: Article

References (50)

1. Increased incidence of non-insulin dependent diabetes mellitus among adolescents
2. Emerging epidemic of type 2 diabetes in youth
3. Non-insulin-dependent diabetes mellitus in childhood and adolescence
4. Non-insulin dependent diabetes mellitus in Mexican-American children
5. Non-insulin dependent diabetes mellitus in childhood
6. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes
7. Insulin-sensitive and insulin-resistant variants in NIDDM
8. Report of the expert committee on the diagnosis and classification of diabetes mellitus
9. Abnormal glucagon secretion in type 2 (noninsulin-dependent) diabetes mellitus: Causes and consequences
10. The β-cell in diabetes
11. The fourth musketeer-from Alexandre Dumas to Claude Bernard
12. Hyperglucagonemia in diabetic ketoacidosis: Its prevalence and significance
13. Glucagon suppression with low-dose intramuscular insulin therapy in diabetic ketoacidosis
14. Plasma glucagon in nonketotic hyperosmolar coma
15. Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus
16. Both glucagon excess and insulin deficiency characterize maturity-onset diabetes mellitus of youth (MODY)
17. Glucagon and its family revisited
18. Glucagon physiology and pathophysiology in the light of new advances
19. Role of glucagon in the pathogenesis of diabetes: The status of the controversy
20. Design and methodologic considerations for the feasibility phase
21. C-Peptide used in the estimation of islet β-cell function in diabetes
22. NCHS. Anthropometric reference data and prevalence of overweight: United States
23. Comparison of the metabolic affects of mixed meal and standard oral glucose tolerance test on glucose, insulin and C-peptide response in healthy, impaired glucose tolerance, mild and severe non-insulin-dependent diabetic subjects
24. Repeated measures analysis of variance
25. Statistics in practice: Comparing the means of several groups
26. Analysis of covarience
27. Implications of the diabetes control and complications trial
28. Standards of medical care for patients with diabetes mellitus
29. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
30. The significant of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects
31. Relationships of C-peptide levels and the C-peptide/bloodsugar ratio with clinical/biochemical variables associated with insulin resistance in orally-treated, well-controlled type 2 diabetic patients
32. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus
33. Increased insulin secretion in puberty: A compensatory response to reductions in insulin sensitivity
34. Pubertal changes in insulin secretion and peripheral insulin sensitivity
35. A quantitative scale of acanthosis nigicans
36. Type 2 diabetes in children and adolescents
37. Obesity increases risk for diabetes
38. Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus
39. Autoantigens IA-2 and GAD in type I (insulin-dependent) diabetes
40. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes
41. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years
42. 65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings
43. β-cells in type II diabetes mellitus
44. Abnormal αcell function in diabetes: Response to carbohydrate and protein ingestion
45. Effect of intermittent physiologic hyperglucagonemia on postprandial plasma glucose levels in normal man
46. The effect of chronic hyperglycemia on the islet B-cell responsiveness in newly diagnosed type 2 diabetes
47. The role of glucagon in non-insulin-dependent (type 2) diabetes mellitus
48. Perspective in diabetes: U.K. Prospective Diabetes Study 16-overview of 6 years' therapy of type II diabetes
49. Progressive deterioration of β-cell function in nonobese type 2 diabetic subjects